182 related articles for article (PubMed ID: 29973123)
1. Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study.
Brooks JV; Ellis SD; Morrow E; Kimminau KS; Thrasher JB
Am J Mens Health; 2018 Sep; 12(5):1719-1727. PubMed ID: 29973123
[TBL] [Abstract][Full Text] [Related]
2. Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions.
Scherr KA; Fagerlin A; Hofer T; Scherer LD; Holmes-Rovner M; Williamson LD; Kahn VC; Montgomery JS; Greene KL; Zhang B; Ubel PA
Med Decis Making; 2017 Jan; 37(1):56-69. PubMed ID: 27510740
[TBL] [Abstract][Full Text] [Related]
3. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
[TBL] [Abstract][Full Text] [Related]
4. Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom.
Philippou Y; Raja H; Gnanapragasam VJ
BMC Urol; 2015 Jun; 15():52. PubMed ID: 26070313
[TBL] [Abstract][Full Text] [Related]
5. Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance.
Orom H; Homish DL; Homish GG; Underwood W
Urol Oncol; 2014 May; 32(4):396-402. PubMed ID: 24332649
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer.
Ehdaie B; Assel M; Benfante N; Malhotra D; Vickers A
Eur Urol; 2017 Jun; 71(6):866-871. PubMed ID: 28129893
[TBL] [Abstract][Full Text] [Related]
7. Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists.
Ellis SD; Hwang S; Morrow E; Kimminau KS; Goonan K; Petty L; Ellerbeck E; Thrasher JB
BMC Cancer; 2021 May; 21(1):649. PubMed ID: 34058998
[TBL] [Abstract][Full Text] [Related]
8. Primary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate Cancer.
Radhakrishnan A; Subramanian L; Rankin AJ; Fetters MD; Wittmann DA; Ginsburg KB; Hawley ST; Skolarus TA
Ann Fam Med; 2024; 22(1):5-11. PubMed ID: 38253492
[TBL] [Abstract][Full Text] [Related]
9. The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review.
Rittenmeyer L; Huffman D; Alagna M; Moore E
JBI Database System Rev Implement Rep; 2016 Feb; 14(2):174-255. PubMed ID: 27536798
[TBL] [Abstract][Full Text] [Related]
10. Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
Mallapareddi A; Ruterbusch J; Reamer E; Eggly S; Xu J
Fam Pract; 2017 Feb; 34(1):90-97. PubMed ID: 28034917
[TBL] [Abstract][Full Text] [Related]
11. A qualitative study to understand guideline-discordant use of imaging to stage incident prostate cancer.
Makarov DV; Sedlander E; Braithwaite RS; Sherman SE; Zeliadt S; Gross CP; Curnyn C; Shedlin M
Implement Sci; 2016 Sep; 11(1):118. PubMed ID: 27590603
[TBL] [Abstract][Full Text] [Related]
12. Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.
Iremashvili V; Manoharan M; Rosenberg DL; Soloway MS
BJU Int; 2013 Apr; 111(4):574-9. PubMed ID: 22564446
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance.
Davison BJ; Breckon E
Patient Educ Couns; 2012 Jun; 87(3):369-74. PubMed ID: 22177658
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer: Time for active surveillance of intermediate-risk disease?
Ahmed HU
Nat Rev Urol; 2013 Jan; 10(1):6-8. PubMed ID: 23147924
[No Abstract] [Full Text] [Related]
15. Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists' recommendations for active treatment or active surveillance: a randomized clinical utility trial.
Peabody JW; DeMaria LM; Tamondong-Lachica D; Florentino J; Czarina Acelajado M; Ouenes O; Richie JP; Burgon T
BMC Urol; 2017 Jul; 17(1):51. PubMed ID: 28673277
[TBL] [Abstract][Full Text] [Related]
16. The effect of urologist experience on choosing active surveillance for prostate cancer.
Chu WG; Kim BJ; Slezak J; Harrison TN; Gelfond J; Jacobsen SJ; Chien GW
World J Urol; 2015 Nov; 33(11):1701-6. PubMed ID: 25761737
[TBL] [Abstract][Full Text] [Related]
17. Perceptions of Urologists About the Conversational Elements Leading to Treatment Decision-Making Among Newly Diagnosed Prostate Cancer Patients.
Adsul P; Wray R; Boyd D; Weaver N; Siddiqui S
J Cancer Educ; 2017 Sep; 32(3):580-588. PubMed ID: 27029194
[TBL] [Abstract][Full Text] [Related]
18. Qualitative study on decision-making by prostate cancer physicians during active surveillance.
Loeb S; Curnyn C; Fagerlin A; Braithwaite RS; Schwartz MD; Lepor H; Carter HB; Sedlander E
BJU Int; 2017 Jul; 120(1):32-39. PubMed ID: 27611479
[TBL] [Abstract][Full Text] [Related]
19. Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
Kim SP; Gross CP; Nguyen PL; Smaldone MC; Shah ND; Karnes RJ; Thompson RH; Han LC; Yu JB; Trinh QD; Ziegenfuss JY; Sun M; Tilburt JC
Med Care; 2014 Jul; 52(7):579-85. PubMed ID: 24926704
[TBL] [Abstract][Full Text] [Related]
20. Factors Influencing Selection of Active Surveillance for Localized Prostate Cancer.
Liu J; Womble PR; Merdan S; Miller DC; Montie JE; Denton BT;
Urology; 2015 Nov; 86(5):901-5. PubMed ID: 26358397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
